Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30
(-1.91%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Laboratories reports 42% rise in Q1 consolidated net profit
>>
Dr Reddy's Laboratories soars on launching Ramelteon Tablets in US Market
>>
Dr Reddy's Laboratories launches Ramelteon Tablets in US Market
>>
Dr. Reddy’s Lab trades in green on the BSE
>>
Dr. Reddy's Lab completes divestment of Zembrace Symtouch, Tosymra to Upsher-Smith
>>
Dr. Reddy’s Laboratories informs about press release
>>
Dr Reddy's Lab launches Fexofenadine HCI, Pseudoephedrine HCI Extended-Release Tablets
>>
USFDA completes audit at Dr. Reddy’s Laboratories’ Hyderabad plant
>>
Dr Reddy's Lab gains on launching OTC store-brand equivalent of Mucinex D Extended Release Tablets
>>
Dr Reddy's Lab launches OTC store-brand equivalent of Mucinex D Extended Release Tablets
<<
<
65
66
67
...143
>
>>